miocamycin has been researched along with fosfomycin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamilton-Miller, JM | 1 |
| Aramaki, M; Ishii, M; Kawakami, A; Koga, T; Motohiro, T; Oda, K; Sakata, Y; Suzuki, K; Tanaka, K; Yamashita, F | 1 |
| Hoshino, E; Noda, T; Sato, T; Uematsu, H | 1 |
| Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T | 1 |
1 trial(s) available for miocamycin and fosfomycin
| Article | Year |
|---|---|
[Evaluation of effectiveness of rokitamycin dry syrup in acute enteritis in pediatrics. A comparative study on rokitamycin and fosfomycin dry syrups].
Topics: Acute Disease; Administration, Oral; Age Factors; Campylobacter fetus; Campylobacter Infections; Child; Child, Preschool; Clinical Trials as Topic; Dosage Forms; Enteritis; Female; Fosfomycin; Humans; Infant; Male; Miocamycin; Multicenter Studies as Topic | 1990 |
3 other study(ies) available for miocamycin and fosfomycin
| Article | Year |
|---|---|
From foreign pharmacopoeias: 'new' antibiotics from old?
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Europe; Fosfomycin; Humans; Josamycin; Miocamycin; Pharmacopoeias as Topic; Spiramycin; United States; Virginiamycin | 1991 |
In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth.
Topics: Amoxicillin; Bacteria, Anaerobic; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Dental Caries; Dental Pulp Diseases; Drug Therapy, Combination; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Miocamycin; Tooth, Deciduous | 1993 |
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells | 2000 |